Risk factors and cognitive domain markers of progression in subjective cognitive decline
Bubu, O. M.; Mbah, A. K.; Bernard, M. A.; Briggs, A. Q.; Faustin, A.; Gurin, L.; Rao, J. A.; Ouedraogo Tall, S.; Osorio, R. S.; Masurkar, A. V.
Show abstract
We evaluated risk factor differences and cognitive domain markers associated with progression in subjects with subjective cognitive decline (SCD) at baseline from the NYU Alzheimers Disease Research Center. We included SCD non-decliners (n = 27), who remained stable, and decliners (n = 24), who progressed to mild cognitive impairment or worse, between the second to sixth yearly follow-up visits. Adjusted mixed-effects models examined group differences and associations between demographic, APOE status, psychometric test performance and comorbidities with longitudinal-decline. Overall, mean (SD) age was 67.4 (9.2) and total follow-up time was 5.1 (1.8) years. Lower education (14.9 (3.2) vs. 17.3 (2.1)), Hispanic ethnicity (50.0% vs. 11.0%), and hypercholesterolemia (aOR: 6.67), p [≤] 0.05 for all, were risk factors for progression in SCD, whereas APOE status was not. Notably, SCD decliners were at increased risk for both amnestic and non-amnestic cognitive-decline with psychometric changes in memory, executive, and language domains (p < 0.001 for all). These findings inform further work on SCD outcomes and related biomarkers, as well as preventive studies that target modifiable risk factors for SCD progression.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- CSF Aβ38 levels are associated with Alzheimer-related decline: implications for γ-secretase modulators 95%
- Susceptibility to postmortem (co)-pathologies in antemortem atrophy-based subtypes of Alzheimer’s disease 93%
- CSF p-tau181 Increases in Patients with Neuronal Intranuclear Inclusion Disease without Amyloid Burden 93%
Similar papers in this journal
Similar papers in this journal
- Sex differences in the association of mild behavioral impairment with cognitive aging 96%
- The Association of Alzheimer’s Disease-related Blood-based Biomarkers with Cognitive Screening Test Performance in the Congolese Population in Kinshasa 96%
- Risk models based on non-cognitive measures may identify presymptomatic Alzheimer’s disease 95%
Similar papers in this journal
- Continuous Associations Between Remote Self-Administered Cognitive Measures and Imaging Biomarkers of Alzheimer’s Disease 95%
- Use of Lecanemab and Donanemab in the Canadian Healthcare System: Evidence, Challenges, and Areas for Future Research 94%
- Subjective cognition trajectories, Alzheimer biomarkers, and incident mild cognitive impairment 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.